1、The state of HIV treatment,testing,and prevention in low-and middle-income countriesISSUE 16,NOVEMBER 20252025HIV MARKETREPORTDISCLAIMER The data sources primarily used for analysis in the report include Clinton Health Access Initiative(CHAI)country teams,Ministry of Health counterparts,stakeholder
2、resources and conversations(e.g.Global Fund,PEPFAR,UNAIDS,Unitaid,WHO,and civil society partners),and published research.CHAI has taken precautions to verify the information shared in the report.However,the analysis in the report is not exhaustive,and the responsibility for the interpretation and us
3、e of the material lies with the reader.The mention of specific companies or products does not imply CHAIs endorsement or recommendation.ACKNOWLEDGMENT This report was made possible through the generous support of Unitaid,with complementary support from the UK Foreign,Commonwealth&Development Office
4、and the Gates Foundation.CONTACT Carolyn Amole Vice President,HIV,Hepatitis,and TB camoleclintonhealthaccess.orgCover images,clockwise from the top:A lab technician at a clinic in Nigeria;a child attends a clinic in Tanzania;a healthcare worker takes stock at a hospital in Lao PDR22025 CHAI HIV Mark
5、et ReportACRONYMS 4EXECUTIVE SUMMARY 6FOREIGN AID CUTS 11HIV PREVENTION 14HIV TESTING 20PEDIATRIC HIV 26ADULT TREATMENT 34ADVANCED HIV DISEASE(AHD)39TREATMENT MONITORING 47APPENDIX A:FORECASTED API DEMAND IN GA LMICS 51APPENDIX B:CHAI ARV BENCHMARK PRICE COMPARISON LIST 53APPENDIX C:NOTES ON METHODO
6、LOGY 54APPENDIX D:REFERENCES 55CONTENTSHIV Market Report32025 CHAI HIV Market ReportTable of Contents3HPThree months of weekly rifapentine and isoniazid3TCLamivudine5FCFlucytosineABCAbacavirAGYWAdolescent girls and young womenAHDAdvanced HIV diseaseAIDSAcquired immunodeficiency syndromeANCAntenatal